Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 15, 2025

Supplementary Figure 3 from Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study

View Full Paper
Ask AI
Bookmark
Share

Authors

BTBianca TesiARAnna RobeliusBBBerivan Baskin

Discussion

Loading...

Member takes

Overview

Prospective cohort study validates genetic guidelines in myeloid neoplasms, showing germline predisposition in patients with telomere length abnormalities.

Key Points

  • Main finding highlights the genetic characteristics of myeloid neoplasms linked to telomere length disorders.
  • Patients with germline predisposition displayed symptoms including cytopenias and lung fibrosis, associated with shorter telomere length.
  • Genetic testing utilized qPCR to analyze telomere length in leukocytes of patients with myeloid neoplasms.
  • Study results enhance understanding of telomere biology disorders in myeloid neoplasms, suggesting new diagnostic pathways.

Cite This Study

Tesi et al. (2025) studied this question.

synapsesocial.com/papers/689a02bce6551bb0af8cc690https://doi.org/10.1158/1078-0432.29568277
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Intermediate and high-risk clonal hematopoiesis in germline predisposition families2025
  2. 2Data from Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study2025
  3. 3Genetically determined telomere length as a risk factor for hematological malignancies: evidence from Mendelian randomization analysis2024 · 4 citations
  4. 4Supplementary Figure 1 from Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study2025
  5. 5Case Series: Clinical Significance of Heterozygous Pathogenic <scp> <i>RTEL1</i> </scp> Variants Identified via Routine Clinical Genetic Diagnostics2025